Hematologic effects of prostaglandins and thromboxanes and inhibitors of their synthesis in the perinatal period.
D000244:Adenosine Diphosphate / Q000097:blood; D000818:Animals; D001773:Blood Cells / Q000502:physiology*; D001792:Blood Platelets / Q000502:physiology; D016861:Cyclooxygenase Inhibitors; D011464:Epoprostenol / Q000378:metabolism; D004912:Erythrocytes / Q000502:physiology; D005228:Fatty Acids, Essential / Q000378:metabolism; D005260:Female; D005333:Fetus / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D007743:Labor, Obstetric / Q000187:drug effects*; D008264:Macrophages / Q000502:physiology; D009504:Neutrophils / Q000502:physiology; D010586:Phagocytes / Q000502:physiology*; D010740:Phospholipases / Q000378:metabolism; D011247:Pregnancy; D011448:Prostaglandin Antagonists / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis / Q000502:physiology*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors; D013931:Thromboxanes / Q000096:biosynthesis / Q000502:physiology*
D016861:Cyclooxygenase Inhibitors; D005228:Fatty Acids, Essential; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D013931:Thromboxanes; D000244:Adenosine Diphosphate; D011464:Epoprostenol; D010740:Phospholipases; D013930:Thromboxane-A Synthase